Xing-wang Xie
Beijing Key Laboratory Of Hepatitis C And Immunotherapy For Liver Disease
Beijing, 100044, China
Beijing, 100044, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A.
Journal: Scientific reports
Published: April 26, 2020
Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis.
Journal: Chinese medical journal
Published: June 13, 2019
Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma.
Journal: American journal of cancer research
Published: April 08, 2019
Effect of Upregulated DNA Replication and Sister Chromatid Cohesion 1 Expression on Proliferation and Prognosis in Hepatocellular Carcinoma.
Journal: Chinese medical journal
Published: December 05, 2018
Direct-acting Antiviral Agents Resistance-associated Polymorphisms in Chinese Treatment-naïve Patients Infected with Genotype 1b Hepatitis C Virus.
Journal: Chinese medical journal
Published: September 30, 2015
2',3'-cyclic nucleotide 3'-phosphodiesterases inhibit hepatitis B virus replication.
Journal: PloS one
Published: August 08, 2013
Correlation between interleukin-28B genetic polymorphisms and primary hepatocellular carcinoma
Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
Published: September 05, 2012
Intestinal immune barrier integrity in rats with nonalcoholic hepatic steatosis and steatohepatitis.
Intestinal immune barrier integrity in rats with nonalcoholic hepatic steatosis and steatohepatitis.
Journal: Chinese medical journal
Published: February 21, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026